ATI RN
Drugs immune system Questions
Question 1 of 5
Isoniazid is a primary antitubercular agent that
Correct Answer: A
Rationale: In the context of the immune system and drug therapy, understanding the key characteristics of isoniazid is crucial for healthcare professionals. The correct answer is A) Requires pyridoxine supplementation. Isoniazid, as a primary antitubercular agent, is known to deplete levels of vitamin B6 (pyridoxine) in the body. Pyridoxine supplementation is necessary to prevent the development of peripheral neuropathy, a common side effect of isoniazid therapy. This is a critical point in the treatment of tuberculosis to ensure patient safety and treatment efficacy. Option B) May discolor the tears, saliva, urine, or feces orange-red is incorrect. This statement does not align with the known side effects of isoniazid. Option C) Causes ocular complications that are reversible if the drug is discontinued is incorrect. Ocular complications are not commonly associated with isoniazid therapy. Option D) May be ototoxic and nephrotoxic is incorrect. While some antitubercular drugs are known to have these side effects, isoniazid is not primarily associated with ototoxicity or nephrotoxicity. Educationally, understanding the specific side effects and management strategies for antitubercular agents like isoniazid is vital for healthcare professionals involved in the care of patients with tuberculosis. By recognizing the need for pyridoxine supplementation with isoniazid therapy, healthcare providers can ensure optimal patient outcomes and minimize the risk of side effects.
Question 2 of 5
Clarithromycin and erythromycin have very similar spectrums of antimicrobial activity. The major advantage of clarithromycin is that
Correct Answer: C
Rationale: In this case, the correct answer is C) Is more active against Mycobacterium avium complex. Clarithromycin has an advantage over erythromycin because it is more active against Mycobacterium avium complex, making it a preferred choice for treating infections caused by this organism. This is a key point to remember when choosing between the two antibiotics for specific infections. Option A) Eradicates mycoplasmal infections in a single dose is incorrect because neither clarithromycin nor erythromycin is typically used to treat mycoplasmal infections in a single dose. These infections usually require a longer course of treatment. Option B) Is active against strains of streptococci that are resistant to erythromycin is incorrect because both clarithromycin and erythromycin have similar spectrums of activity against streptococci, so there is no advantage of clarithromycin over erythromycin in this context. Option D) Does not inhibit live drug-metabolizing enzymes is incorrect because both clarithromycin and erythromycin can inhibit cytochrome P450 enzymes, which are involved in drug metabolism. Understanding the differences between antibiotics like clarithromycin and erythromycin is crucial for healthcare professionals to make informed decisions when prescribing antibiotics. Knowing the specific advantages of each drug can lead to better treatment outcomes and lower the risk of antibiotic resistance.
Question 3 of 5
All of the following factors may increase the risk of nephrotoxicity from gentamicin therapy except
Correct Answer: D
Rationale: In the context of gentamicin therapy and the risk of nephrotoxicity, understanding the factors that contribute to this adverse effect is crucial for healthcare professionals. Option A, age over 70 years, is a risk factor for nephrotoxicity because renal function tends to decline with age, making elderly individuals more vulnerable to drug-induced kidney damage. Prolonged courses of gentamicin therapy (Option B) increase the cumulative exposure to the drug, heightening the risk of nephrotoxicity. Concurrent amphotericin B therapy (Option C) is also a risk factor as both drugs have nephrotoxic potential, and their combined use can synergistically increase kidney damage. The correct answer, Option D, states that trough gentamicin levels below 2 mg/ml do not increase the risk of nephrotoxicity. This is because higher drug concentrations are more likely to cause kidney damage. Monitoring and maintaining appropriate drug levels within the therapeutic range are essential to minimize toxicity while ensuring efficacy. In an educational context, it is important to emphasize the significance of individualizing drug therapy based on patient characteristics and closely monitoring for adverse effects. Understanding the risk factors associated with nephrotoxicity from gentamicin helps healthcare providers make informed decisions to optimize patient outcomes and prevent harm.
Question 4 of 5
Streptomycin has no useful activity in the treatment of
Correct Answer: C
Rationale: Streptomycin, an antibiotic, is effective against various bacterial infections but has no useful activity in treating Lyme disease. This is because Lyme disease is caused by a different type of bacteria called Borrelia burgdorferi, which is not susceptible to streptomycin. In contrast, streptomycin is commonly used to treat tuberculosis (Option D) due to its effectiveness against the bacteria Mycobacterium tuberculosis. It is also effective in treating bubonic plague (Option A) caused by Yersinia pestis, brucellosis (Option B) caused by Brucella species, but not Lyme disease. From an educational perspective, understanding the specific spectrum of activity of antibiotics is crucial for effective clinical decision-making. This question highlights the importance of selecting the right antibiotic based on the causative organism, thereby emphasizing the principles of targeted therapy in managing infectious diseases.
Question 5 of 5
Regarding the recently introduced lipid formulation of amphotericin B, which one of the following statements is accurate?
Correct Answer: D
Rationale: The correct answer is D) They may decrease nephrotoxicity of amphotericin B. Rationale: The lipid formulation of amphotericin B has been developed to reduce the nephrotoxicity associated with conventional amphotericin B. By incorporating amphotericin B into lipid molecules, the drug is believed to be better tolerated by patients, leading to reduced kidney damage. This formulation allows for a slower release of the drug, potentially decreasing its toxicity to the kidneys. Option A is incorrect because amphotericin B's primary mode of action is binding to ergosterol in fungal cell membranes, not to the lipids of the formulation. Option B is incorrect as lipid formulations are generally more expensive due to the added technology involved. Option C is incorrect because the primary benefit of lipid formulations is not increased tissue uptake but rather reduced toxicity. Educational Context: Understanding the rationale behind the development of lipid formulations of drugs like amphotericin B is crucial for healthcare professionals. It highlights the importance of drug delivery systems in minimizing adverse effects and improving patient outcomes. By grasping these concepts, healthcare providers can make informed decisions when selecting appropriate treatment options for patients with fungal infections, taking into consideration both efficacy and safety profiles.